title: Prevalence of hepatitis B and C in donated blood from the jazan region of saudi arabia.
abstract: BACKGROUND
  Infections caused by the hepatitis B virus (HBV) and the hepatitis C virus (HCV) are global public health problems. The safety of donated blood can be estimated by monitoring the prevalence of viral markers in the donor population. The present study was carried out in the Jazan region to determine the prevalence of HBV and HCV among Saudi blood donors.
  
  
  METHODS
  Over a period of six years (January 2004 to December 2009), a total of 29 949 blood units were collected from healthy voluntary and replacement native Saudi blood donors. The donated units were serologically screened for hepatitis B surface antigen (HBsAg), antibody to hepatitis B core antigen (anti-HBc), and antibody to hepatitis C virus (anti-HCV). These data were then analysed.
  
  
  RESULTS
  HBsAg was positive in 3.8% of the blood units that were collected, the blood units with anti-HCV seropositivity had the lowest prevalence (0.41%), and the prevalence of HBsAg was highest in the group that was > 46 years of age. A significant decline in the prevalence of HBV infection has been observed, from 5.6% in 2004 to 2.3% in 2009 (P < 0.001).
  
  
  CONCLUSIONS
  The present study showed that the prevalence of HBV and HCV was in a significant decline from 2004 to 2009, and the prevalence of HBsAg and anti-HCV significantly increased with age.
authors: College of Health Sciences, Jazan University, P.O Box 1485, Jazan 45142, Saudi Arabia.
authors: Saleh
authors: S
authors: Mohammed Abdullah
keywords: Jazan; Saudi Arabia; blood donors; hepatitis B virus; hepatitis C virus; prevalence
references: Saudi Med J. 2003 Jul;24 Suppl 2:S81-6
references: 12897907
references: Saudi Med J. 2005 Feb;26(2):270-3
references: 15770304
references: Saudi Med J. 2004 Jan;25(1):26-33
references: 14758374
references: Virol J. 2009 Dec 22;6:227
references: 20028507
references: Transfusion. 2009 Aug;49(8):1609-20
references: 19413732
references: Science. 1977 Jul 1;197(4298):17-25
references: 325649
references: Gastroenterology. 1993 Apr;104(4):955-63
references: 8385046
references: Blood Transfus. 2009 Oct;7(4):293-9
references: 20011640
references: J Med Virol. 2008 Apr;80(4):577-82
references: 18297707
references: Indian J Med Res. 2006 Jan;123(1):37-42
references: 16567866
references: Vox Sang. 2006 Jul;91(1):1-12
references: 16756595
references: J Hepatol. 1995;22(1 Suppl):38-41
references: 7602074
references: Ann Saudi Med. 1999 Mar-Apr;19(2):87-92
references: 17337941
references: Int J Infect Dis. 2008 Sep;12(5):495-9
references: 18400539
references: Clin Microbiol Rev. 1999 Apr;12(2):351-66
references: 10194463
references: Ann Saudi Med. 1993 May;13(3):231-6
references: 17590667
references: Transfusion. 2007 Jan;47(1):74-9
references: 17207233
references: Bull World Health Organ. 2010 Nov 1;88(11):801-2
references: 21076557
references: Virol J. 2012 Apr 14;9:82
references: 22500577
references: Hepatology. 1999 Sep;30(3):595-601
references: 10462362
references: J Med Virol. 2000 Dec;62(4):450-5
references: 11074473
references: Saudi Med J. 2000 Oct;21(10):942-4
references: 11369958
references: Clin Lab Haematol. 2004 Jun;26(3):225-8
references: 15163322
references: Jpn J Infect Dis. 2004 Apr;57(2):49-51
references: 15118208
references: Transfusion. 2001 Sep;41(9):1081-5
references: 11552062
references: J Clin Virol. 2001 Jun;21(3):229-37
references: 11397659
references: Br Med Bull. 2004 Aug 31;70:15-28
references: 15339855
references: Science. 1989 Apr 21;244(4902):359-62
references: 2523562
references: Saudi Med J. 2003 Sep;24(9):991-5
references: 12973485